Company intelligence / Profile preview

BAIBYS Fertility

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

BAIBYS Fertility has developed an autonomous AI and robotics-driven system that analyzes live sperm cells in real time using machine vision and artificial intelligence. The device evaluates sperm based on motility and morphology at high magnification per WHO criteria. It then autonomously selects optimal sperm for microinjection in IVF procedures. The technology aims to improve fertilization rates, pregnancy rates, reduce birth defects associated with suboptimal sperm selection, lower costs/time per cycle versus manual methods, and make advanced fertility treatments more accessible globally.

Therapeutic areas: Women's HealthMen's Health
Modalities: DeviceAI-based platformRobotics-based platform
Industry: Digital Health Medical Devices

Partnerships

ROHTO Pharmaceutical (investor/strategic partner)

Beyond the preview

Go deeper on BAIBYS Fertility.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAIBYS Fertility.

Explore the full profile